Table 4.
Outcomes | Endocut | Forced coagulation | P |
---|---|---|---|
Patients eligible for first SC, n | 431 | 426 | |
Patients with first SC, n (%) | 339 (78.7) | 336 (78.9) | .832 |
Time to first SC, mo, median (IQR) | 6 (4–7) | 6 (4–8) | .006 |
Polyp resection sites available for evaluation, n | 369 | 351 | .256 |
Polyp resection sites identified, n (%) | 333 (90.2) | 322 (91.7) | .484 |
Sites with biopsy or histology, n (%)a | 280 (75.9) | 256 (72.9) | .365 |
Recurrence, n (%)a | 61 (16.5) | 61 (17.4) | .762 |
Visible | 39 (10.6) | 50 (14.2) | .134 |
Not visible | 22 (6.0) | 11 (3.1) | .070 |
Among all polyp sites; if restricted to those that were identified: 18.3% vs 18.9%, respectively.